文献速递儿科与产科急症

41周引产与期待管理至42周引产(瑞典过期妊娠引产研究,SWEPIS):多中心、开放标签、随机、优效性试验

Induction of labour at 41 weeks versus expectant management and induction of labour at 42 weeks (SWEdish Post-term Induction Study, SWEPIS): multicentre, open label, randomised, superiority trial.
PubMed 文献 · BMJ · 2019-11-20
一句话结论低危单胎妊娠41周引产与期待管理至42周引产相比,主要围产期复合结局无显著差异,但围产期死亡率在期待管理组更高(6例 vs 0例),作者认为应在不晚于41周时提供引产。

这项多中心、开放标签、随机优效性试验在瑞典14家医院纳入2760例低危无合并症单胎妊娠孕妇,1:1随机分为41周引产组(1381例)和期待管理至42周引产组(1379例)。主要复合围产期结局两组无显著差异:引产组2.4%(33/1381)vs 期待管理组2.2%(31/1379),RR 1.06(95%CI 0.65-1.73),P=0.90。因期待管理组围产期死亡率显著更高(6例 vs 0例,P=0.03)而提前终止。剖宫产、器械阴道分娩或任何严重孕产妇并发症比例两组无差异。作者认为结果需谨慎解读,但应在不晚于41周时向孕妇提供引产。

要点

  • 低危单胎妊娠41周引产组主要围产期复合结局2.4%(33/1381),期待管理至42周组2.2%(31/1379),RR 1.06(95%CI 0.65-1.73),P=0.90,无显著差异。
  • 期待管理至42周组发生6例围产期死亡(5例死产和1例早期新生儿死亡),41周引产组0例,P=0.03,研究因此提前终止。
  • 剖宫产、器械阴道分娩或任何严重孕产妇并发症比例两组无差异。
  • 作者结论:41周引产与期待管理至42周相比主要复合结局无显著差异,但观察到围产期死亡率降低且不增加孕产妇不良结局,结果需谨慎解读。
  • 作者建议:应在不晚于41周时向孕妇提供引产,引产可能是降低死产率的少数干预措施之一。

处置流程与药物剂量

  • 41周引产组:在妊娠41周时进行引产。
  • 期待管理组:期待管理并在妊娠42周时进行引产。

研究设计与关键结果

  • 研究类型:多中心、开放标签、随机对照优效性试验,纳入2760例低危无合并症单胎妊娠孕妇,1:1随机分为41周引产组(1381例)和期待管理至42周引产组(1379例)。
  • 主要复合围产期结局包括死产、新生儿死亡、5分钟Apgar评分小于7、脐动脉pH小于7.00或代谢性酸中毒(pH<7.05且碱缺失>12 mmol/L)、缺氧缺血性脑病、颅内出血、惊厥、胎粪吸入综合征、72小时内机械通气或产科臂丛神经损伤中的一项或多项;引产组2.4%(33/1381)vs 期待管理组2.2%(31/1379),RR 1.06(95%CI 0.65-1.73),P=0.90。
  • 围产期死亡:引产组0例,期待管理组6例(5例死产和1例早期新生儿死亡),P=0.03。
  • 剖宫产、器械阴道分娩或任何严重孕产妇并发症比例两组无差异。
  • 研究因期待管理组围产期死亡率显著更高而提前终止。

证据类型、等级与局限

  • 证据类型:多中心、开放标签、随机对照优效性试验。
  • 局限:研究因期待管理组围产期死亡率显著更高而提前终止;作者认为结果应谨慎解读。

对床旁实践的改变

  • 作者认为,尽管结果应谨慎解读,应在不晚于41周时向孕妇提供引产,引产可能是降低死产率的少数干预措施之一。

提炼说明

  • 本条依据论文摘要整理;摘要未涉及「适用人群与场景」「诊断标准与关键阈值」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
  • 另有 1 条提炼内容因数值无法与原文逐一核对而未列出,请以原文为准。
英文原文(摘要)· 点击展开

OBJECTIVE: To evaluate if induction of labour at 41 weeks improves perinatal and maternal outcomes in women with a low risk pregnancy compared with expectant management and induction of labour at 42 weeks.

DESIGN: Multicentre, open label, randomised controlled superiority trial.

SETTING: 14 hospitals in Sweden, 2016-18.

PARTICIPANTS: 2760 women with a low risk uncomplicated singleton pregnancy randomised (1:1) by the Swedish Pregnancy Register. 1381 women were assigned to the induction group and 1379 were assigned to the expectant management group.

INTERVENTIONS: Induction of labour at 41 weeks and expectant management and induction of labour at 42 weeks.

MAIN OUTCOME MEASURES: The primary outcome was a composite perinatal outcome including one or more of stillbirth, neonatal mortality, Apgar score less than 7 at five minutes, pH less than 7.00 or metabolic acidosis (pH <7.05 and base deficit >12 mmol/L) in the umbilical artery, hypoxic ischaemic encephalopathy, intracranial haemorrhage, convulsions, meconium aspiration syndrome, mechanical ventilation within 72 hours, or obstetric brachial plexus injury. Primary analysis was by intention to treat.

RESULTS: The study was stopped early owing to a significantly higher rate of perinatal mortality in the expectant management group. The composite primary perinatal outcome did not differ between the groups: 2.4% (33/1381) in the induction group and 2.2% (31/1379) in the expectant management group (relative risk 1.06, 95% confidence interval 0.65 to 1.73; P=0.90). No perinatal deaths occurred in the induction group but six (five stillbirths and one early neonatal death) occurred in the expectant management group (P=0.03). The proportion of caesarean delivery, instrumental vaginal delivery, or any major maternal morbidity did not differ between the groups.

CONCLUSIONS: This study comparing induction of labour at 41 weeks with expectant management and induction at 42 weeks does not show any significant difference in the primary composite adverse perinatal outcome. However, a reduction of the secondary outcome perinatal mortality is observed without increasing adverse maternal outcomes. Although these results should be interpreted cautiously, induction of labour ought to be offered to women no later than at 41 weeks and could be one (of few) interventions that reduces the rate of stillbirths.

TRIAL REGISTRATION: Current Controlled Trials ISRCTN26113652.

来源:BMJ,查看原文。版权归原作者所有。

参考来源

  1. Wennerholm UB, Saltvedt S, Wessberg A, et al. Induction of labour at 41 weeks versus expectant management and induction of labour at 42 weeks (SWEdish Post-term Induction Study, SWEPIS): multicentre, open label, randomised, superiority trial. BMJ. 2019. PMID: 31748223. doi:10.1136/bmj.l6131

供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。